Pds biotechnology announces principal investigator and independent data monitoring committee for its phase 2 clinical collaboration with merck

Pds biotechnology announces principal investigator and independent data monitoring committee for its phase 2 clinical collaboration with merck.pds biotechnology corp - jared weiss will be principal investigator for co's phase 2 versatile-002 study in collaboration with merck.pds biotechnology corp - combination study is expected to be initiated in next three to four months.
PDSB Ratings Summary
PDSB Quant Ranking